225 related articles for article (PubMed ID: 23049685)
1. Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt--that is the question.
Bell TG; Makondo E; Martinson NA; Kramvis A
PLoS One; 2012; 7(10):e45750. PubMed ID: 23049685
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
3. [Investigation of occult hepatitis B in HIV infected patients].
Altınbaş A; Ergünay K; Calık Başaran N; Alp A; Turgut D; Hasçelik G; Uzun Ö; Unal S
Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
[TBL] [Abstract][Full Text] [Related]
4. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients.
Mudawi H; Hussein W; Mukhtar M; Yousif M; Nemeri O; Glebe D; Kramvis A
Int J Infect Dis; 2014 Dec; 29():65-70. PubMed ID: 25449238
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
[TBL] [Abstract][Full Text] [Related]
6. Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa.
Barth RE; Huijgen Q; Tempelman HA; Mudrikova T; Wensing AM; Hoepelman AI
J Med Virol; 2011 Jun; 83(6):929-34. PubMed ID: 21503902
[TBL] [Abstract][Full Text] [Related]
7. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.
Lukhwareni A; Burnett RJ; Selabe SG; Mzileni MO; Mphahlele MJ
J Med Virol; 2009 Mar; 81(3):406-12. PubMed ID: 19152393
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus in HIV-infected patients in northeastern South Africa: prevalence, exposure, protection and response to HAART.
Ayuk J; Mphahlele J; Bessong P
S Afr Med J; 2013 May; 103(5):330-3. PubMed ID: 23971125
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of occult hepatitis B infection among treatment-naive persons living with HIV in Ghana.
Salia E; Nartey YA; Djankpa FT; Pappoe F; Nuvor SV; Obiri-Yeboah D
PLoS One; 2024; 19(6):e0305862. PubMed ID: 38924017
[TBL] [Abstract][Full Text] [Related]
10. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
Gupta S; Singh S
BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
[TBL] [Abstract][Full Text] [Related]
11. Genotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern Africa.
Makondo E; Bell TG; Kramvis A
PLoS One; 2012; 7(9):e46345. PubMed ID: 23029487
[TBL] [Abstract][Full Text] [Related]
12. Response of hepatitis B virus to antiretroviral treatment containing lamivudine in HBsAg-positive and HBsAg-negative HIV-positive South African adults.
Singh L; Bell TG; Yousif M; Kramvis A
J Med Virol; 2019 May; 91(5):758-764. PubMed ID: 30515847
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal.
Toyé RM; Lô G; Diop-Ndiaye H; Cissé AM; Ndiaye AJS; Kébé-Fall K; Dramé A; Cohen D; Pujol FH; Mboup S; Boye CS; Chemin I; Laborde-Balen G; Taverne B; Touré-Kane C
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101502. PubMed ID: 32828748
[TBL] [Abstract][Full Text] [Related]
14. HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
Hamers RL; Zaaijer HL; Wallis CL; Siwale M; Ive P; Botes ME; Sigaloff KC; Hoepelman AI; Stevens WS; Rinke de Wit TF;
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):174-82. PubMed ID: 23892239
[TBL] [Abstract][Full Text] [Related]
15. Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations.
Sucupira MV; Mello FC; Santos EA; Niel C; Rolla VC; Arabe J; Gomes SA
Mem Inst Oswaldo Cruz; 2006 Sep; 101(6):655-60. PubMed ID: 17072479
[TBL] [Abstract][Full Text] [Related]
16. Occult hepatitis B in HIV-infected patients.
Shire NJ; Rouster SD; Rajicic N; Sherman KE
J Acquir Immune Defic Syndr; 2004 Jul; 36(3):869-75. PubMed ID: 15213572
[TBL] [Abstract][Full Text] [Related]
17. Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features.
Morsica G; Ancarani F; Bagaglio S; Maracci M; Cicconi P; Cozzi Lepri A; Antonucci G; Bruno R; Santantonio T; Tacconi L; Baldelli F; Piscopo R; Santoro D; Lazzarin A; D'Arminio Monforte A;
Infection; 2009 Oct; 37(5):445-9. PubMed ID: 19669092
[TBL] [Abstract][Full Text] [Related]
18. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients.
Shire NJ; Rouster SD; Stanford SD; Blackard JT; Martin CM; Fichtenbaum CJ; Sherman KE
J Acquir Immune Defic Syndr; 2007 Mar; 44(3):309-14. PubMed ID: 17159656
[TBL] [Abstract][Full Text] [Related]
19. Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared.
Wandeler G; Mulenga L; Vinikoor MJ; Kovari H; Battegay M; Calmy A; Cavassini M; Bernasconi E; Schmid P; Bolton-Moore C; Sinkala E; Chi BH; Egger M; Rauch A;
Int J Infect Dis; 2016 Oct; 51():97-102. PubMed ID: 27596685
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence.
Bivigou-Mboumba B; Amougou-Atsama M; Zoa-Assoumou S; M'boyis Kamdem H; Nzengui-Nzengui GF; Ndojyi-Mbiguino A; Njouom R; François-Souquière S
PLoS One; 2018; 13(1):e0190592. PubMed ID: 29315352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]